Surface glycan targeting for cancer nano-immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Surface glycan targeting for cancer nano-immunotherapy

Published:2022-02 Issue: Volume:342 Page:321-336
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Choi Yonghyun,Kim Jiwon,Chae Jayoung,Hong Joohye,Park Jongjun,Jeong Eunseo,Kim Hayoung,Tanaka Masayoshi,Okochi Mina,Choi Jonghoon

Funder

Japan Agency for Medical Research and Development

National Research Foundation of Korea

Ministry of Science and ICT, South Korea

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference137 articles.

1. Targeting glycosylation: a new road for cancer drug discovery;Costa;Trends Cancer,2020

2. Glycosylation in cellular mechanisms of health and disease;Ohtsubo;Cell,2006

3. Glycosylation in cancer: mechanisms and clinical implications;Pinho;Nat. Rev. Cancer,2015

4. Quantitative lectinhistochemical and lmmunohistochemical studies on the occurrence of alpha(2,3)- and alpha(2,6)-linked sialic acid residues in colorectal carcinomas;Mathias;Cancer,1995

5. Glycan motif profiling reveals plasma sialyl-Lewis x elevations in pancreatic cancers that are negative for sialyl-Lewis a;Tang;Mol. Cell. Proteomics,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Classification and Molecular Functions of Heparan Sulfate Proteoglycans and Their Molecular Mechanisms with the Receptor;Biologics;2024-03-28

2. Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer;International Journal of Biological Macromolecules;2023-09

3. Therapeutic targeting of aberrant sialylation for prevention of chemoresistance and metastasis in triple negative breast cancer;Journal of Drug Delivery Science and Technology;2023-09

4. Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy;Advanced Healthcare Materials;2023-08-11

5. Cellular Membrane Components‐Mediated Cancer Immunotherapeutic Platforms;Macromolecular Bioscience;2023-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3